FOURIER LEGACY
Long-term Study of LDL-c Lowering with Evolocumab: Observational Follow-up after the FOURIER OUTCOMES Trial
- Stage
- klaar
- Medicine
- none
- Population
- ASCVD
- Phase
- IV
- First Patient In
- 12 March 2020
- Last Patient In
- 9 February 2021
- Last Patient Last Visit
- -
National Lead
prof. dr. J. W. Jukema
Cardioloog
Study Director
